JP MORGAN/CALL/TEVA PHARMACEUTICAL INDUSTRIES/12.5/1/17.01.25 Share Price

Warrant

DE000JL6SDK7

Market Closed - Börse Stuttgart 09:43:30 14/06/2024 BST
5.27 EUR +5.40% Intraday chart for JP MORGAN/CALL/TEVA PHARMACEUTICAL INDUSTRIES/12.5/1/17.01.25
Current month+8.21%
1 month+6.90%
Date Price Change
14/06/24 5.27 +5.40%
13/06/24 5 -4.58%
12/06/24 5.24 +9.39%
11/06/24 4.79 +1.70%
10/06/24 4.71 +3.52%

Delayed Quote Börse Stuttgart

Last update June 14, 2024 at 09:43 am

More quotes

Static data

Product typeWarrant Plain-Vanilla
Buy / SellCALL
Underlying TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Issuer J.P. Morgan
WKN JL6SDK
ISINDE000JL6SDK7
Date issued 14/06/2023
Strike 12.5 $
Maturity 17/01/2025 (215 Days)
Parity 1 : 1
Emission price 0.62
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 5.27
Lowest since issue 0.62
Spread 2
Spread %28.29%

Company Profile

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Sector
-
More about the company

Ratings for Teva Pharmaceutical Industries Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Teva Pharmaceutical Industries Limited

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
17.16 USD
Average target price
18.34 USD
Spread / Average Target
+6.85%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW